Bronchopulmonary dysplasia - Impact of surfactant replacement therapy

被引：11
|
作者：
McColley, SA
机构：
[1] Northwestern Univ, Sch Med, Div Pediat Pulm & Crit Care Med, Chicago, IL USA
[2] Childrens Mem Med Ctr, Cyst Fibrosis Ctr, Chicago, IL USA
来源：
PEDIATRIC CLINICS OF NORTH AMERICA | 1998年 / 45卷 / 03期
关键词：
D O I：
10.1016/S0031-3955(05)70028-6
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Bronchopulmonary dysplasia is a major contributor to the morbidity and mortality of infants born prematurely. Surfactant replacement therapy has had a significant impact on the death rate from respiratory distress syndrome, yet the impact on bronchopulmonary dysplasia is minimal. Despite these findings, the overall incidence and severity of bronchopulmonary dysplasia are likely to decline over time as neonatal care continues to advance.
引用
收藏
页码：573 / +
页数：15
相关论文
共 50 条
  • [31] DRUG-THERAPY FOR BRONCHOPULMONARY DYSPLASIA
    DAVIS, JM
    SINKIN, RA
    ARANDA, JV
    PEDIATRIC PULMONOLOGY, 1990, 8 (02) : 117 - 125
  • [32] Impact of bronchopulmonary dysplasia on brain and retina
    Poon, Annie Wing Hoi
    Ma, Emilie Xiao Hang
    Vadivel, Arul
    Jung, Suna
    Khoja, Zehra
    Stephens, Laurel
    Thebaud, Bernard
    Wintermark, Pia
    BIOLOGY OPEN, 2016, 5 (04): : 475 - 483
  • [33] The economic impact of prematurity and bronchopulmonary dysplasia
    María Álvarez-Fuente
    Luis Arruza
    Marta Muro
    Carlos Zozaya
    Alejandro Avila
    Paloma López-Ortego
    Carmen González-Armengod
    Alba Torrent
    Jose Luis Gavilán
    María Jesús del Cerro
    European Journal of Pediatrics, 2017, 176 : 1587 - 1593
  • [34] The Impact of Bronchopulmonary Dysplasia on Childhood Outcomes
    DeMauro, Sara B.
    CLINICS IN PERINATOLOGY, 2018, 45 (03) : 439 - +
  • [35] Cardiovascular impact and sequelae of bronchopulmonary dysplasia
    Yallapragada, Sushmita G.
    Savani, Rashmin C.
    Goss, Kara N.
    PEDIATRIC PULMONOLOGY, 2021, 56 (11) : 3453 - 3463
  • [36] THE CLINICAL USE OF REPLACEMENT SURFACTANTS IN THE PREVENTION OF BRONCHOPULMONARY DYSPLASIA
    BRYAN, MH
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1987, 10 (04): : A100 - A100
  • [37] SURFACTANT PROTEIN-A DEFICIENCY IN A PRIMATE MODEL OF BRONCHOPULMONARY DYSPLASIA
    KING, RJ
    COALSON, JJ
    DELEMOS, RA
    GERSTMANN, DR
    SEIDNER, SR
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 151 (06) : 1989 - 1997
  • [38] PREVENTION OF BRONCHOPULMONARY DYSPLASIA: ARE INTRATRACHEAL STEROIDS WITH SURFACTANT A MAGIC BULLET?
    Yeh, Tsu F.
    PEDIATRIC PULMONOLOGY, 2016, 51 : S34 - S35
  • [39] Does surfactant administration reduce the incidence of bronchopulmonary dysplasia (BPD)?
    Cifuentes, J
    Mariani, G
    Zola, EM
    Mitchell, B
    Carlo, WA
    PEDIATRIC RESEARCH, 1996, 39 (04) : 1192 - 1192
  • [40] Substrate utilization and kinetics of surfactant metabolism in evolving bronchopulmonary dysplasia
    Spence, KL
    Zozobrado, JC
    Patterson, BW
    Hamvas, A
    JOURNAL OF PEDIATRICS, 2005, 147 (04): : 480 - 485
12345